BioWorld MedTech

July 6, 2017

Edwards wins FDA approval for resilient heart valve device

Edwards Lifesciences Corp. received FDA approval for its Inspiris Resilia aortic valve. The Irvine, Calif.-based company said the valve is resistant to calcification, and leads the way for a new class of resilient heart valve devices. Read More

Fingerstick-free, disposable CGMs (and more) are on the way, but when?

NICE sees economics of Abbott's Freestyle Libre CGM as 'uncertain'

U.K. industry leaders encouraged by ministers' stance on post-Brexit drug/device regulation

U.S. stent makers view India price caps with suspicion

Other news to note

Financings

Daily M&A

Product briefs

Regulatory front

BioWorld MedTech's Oncology Extra

Today's news in brief

BioWorld

BioWorld briefs for April 9, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for April 8, 2025.

Many med-tech company supply chains protected from tariffs

BioWorld MedTech

In the wake of the pandemic, many leading med-tech companies took steps to on-shore and near-shore manufacturing, a move that could protect significant numbers of...

Caution tape displaying US flag, tariffs

Biopharma exempt from US reciprocal tariffs, but not untouched

BioWorld

At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...

Impact of Trump tariffs on med tech proving difficult to anticipate

BioWorld MedTech

The Trump administration’s declaration of a new round of tariffs did not sit well with trade associations, but the impact of those tariffs may vary somewhat by...